Klausymai
Komitetui leidžiama rengti klausymą konkrečia darbo tema, kuriame kviečiami dalyvauti ekspertai. Du ar keli komitetai gali rengti bendrus klausymus. Dauguma komitetų rengia reguliarius klausymus, kadangi juose galima sužinoti ekspertų nuomonę ir aptarti pagrindinius klausimus. Šiame puslapyje rasite visą turimą informaciją, susijusią su komitetų klausymais, įskaitant programas ir pranešėjų kalbas.
On 27 May, the Special Committee on Beating Cancer put the spotlight on the use of artificial intelligence (AI) in cancer research, cancer care and personalised cancer medicine and issues related to data protection during a public hearing with 8 leading experts in the field and the European Commission. The public hearing was organised in association with the Special Committee on Artificial Intelligence in a Digital Age (AIDA).
Lessons from a public health crisis: Impact of the COVID-19 pandemic on cancer care
BECA MEPs discussed the results of the public consultation on the "Impact of the COVID-19 pandemic on cancer prevention, health services, cancer patients and research" on 10 May 2021. A copy of the synopsis report with a summary of the findings and recommendations is available in the link below.
On Monday 10 May 2021, the Members of the Beating Cancer Committee discussed the financing of Europe's Beating Cancer Plan during an exchange of views with the Council and the European Commission. They also examined the Union's legislative competences in policies for fighting cancer together with the legal services of the European Parliament and the European Commission.
On 15 April, the Beating Cancer Committee explored how the EU could further promote and facilitate cooperation and the sharing of knowledge, expertise and data on cancer research and care, for instance through the European Reference Networks and cancer registries, but also by improving the cross-border healthcare directive.
The Beating Cancer Committee took a close look at cancer screening and early detection during a public hearing with 9 leading experts and European Commission representatives on 18 March. MEPs discussed about the role of cancer registries, A.I. and big data, and screening for cervical cancer, breast cancer, colorectal and gastric cancer, lung cancer and prostate cancer. Big disparities in cancer screening still exist between and within EU countries, despite the fact that it can save lives.
On 23 February, the Special Committee on Beating Cancer put the spotlight on paediatric, adolescent and rare cancers. The public hearing addressed research, treatment and rare cancer care and the rights and needs of patients, parents and survivors and caregivers.
On World Cancer Day, 4 February, the Special Committee on Beating Cancer examined the alarming impact of the COVID19-pandemic and other health threats on cancer during a public hearing in the European Parliament.
On Thursday 28 January, MEPs from the Beating Cancer committee discussed with ten leading experts how to deliver the best possible care to cancer patients in the EU. Topics ranged from cancer drugs to multidisciplinary cancer care, with a specific angle on paediatric and rare cancers and the social determinants in accessing cancer care.
The Beating Cancer committee (BECA) put patients and their caregivers first on Monday 11 January 2021during a hearing that was entirely dedicated to patients' experiences and their recommendations for the forthcoming BECA report.
On Friday 11 December the BECA committee heard from seven leading specialists in cancer prevention about the effect the environment can have on everybody's risk of developing cancer, including radiation, air pollution, exposure to chemicals and pesticides, and being exposed to carcinogens at work.
On Wednesday 2 December from 9.00 - 12.00 the BECA committee discussed with seven leading specialists in cancer prevention about the most common causes of cancer related to lifestyle such as tobacco - and alcohol use, nutrition and physical activity, and discuss prevention strategies. All the experts' presentations and the webstreaming link to watch the hearing again can be found below.
On 12 November, four high-level experts provided Members with in-depth information on how to support cancer research in terms of strengthening prevention, diagnosis, treatment and innovation, also with a view to achieving the new Mission on Cancer within Horizon Europe, including financial support. The hearing addressed areas where Member States alone cannot be successful, as in the case of child cancer, rare cancers or research into unknown causes of cancer, which represent 50 % of the cases.